These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10937400)

  • 1. Cost effectiveness analysis of school based Mantoux screening for TB infection.
    Lowin A; Slater J; Hall J; Alperstein G
    Aust N Z J Public Health; 2000 Jun; 24(3):247-53. PubMed ID: 10937400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
    Brassard P; Steensma C; Cadieux L; Lands LC
    Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. School-based screening for tuberculous infection. A cost-benefit analysis.
    Mohle-Boetani JC; Miller B; Halpern M; Trivedi A; Lessler J; Solomon SL; Fenstersheib M
    JAMA; 1995 Aug 23-30; 274(8):613-9. PubMed ID: 7637141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of tuberculosis infection among primary school-entry children in Sydney.
    Alperstein G; Morgan KR; Fett MJ; Nossar V; Stewart GJ
    Aust N Z J Public Health; 1996 Apr; 20(2):123-8. PubMed ID: 8799085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis.
    Macintyre CR; Plant AJ; Hendrie D
    Health Econ; 2000 Jul; 9(5):411-21. PubMed ID: 10903541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea.
    Sohn H; Kim HY; Lee SH
    Int J Tuberc Lung Dis; 2018 May; 22(5):496-503. PubMed ID: 29663953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A screening strategy for latent tuberculosis in healthcare workers: Cost-effectiveness and budget impact of universal versus targeted screening.
    Png ME; Yoong J; Ong CWM; Fisher D; Bagdasarian N
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):341-349. PubMed ID: 30786941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
    Diel R; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
    Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
    Diel R; Nienhaus A; Loddenkemper R
    Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct costs of three models for the screening of latent tuberculosis infection.
    Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2006 Jul; 28(1):45-50. PubMed ID: 16611659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk/cost analysis of alternative screening intervals for occupational tuberculosis infection.
    Nicas M
    Am Ind Hyg Assoc J; 1998 Feb; 59(2):104-12. PubMed ID: 9487664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling schistosomiasis: the cost-effectiveness of alternative delivery strategies.
    Guyatt H; Evans D; Lengeler C; Tanner M
    Health Policy Plan; 1994 Dec; 9(4):385-95. PubMed ID: 10139471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Kowada A
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of tuberculosis infection among Year 8 schoolchildren in inner Sydney in 1992.
    Alperstein G; Fett MJ; Reznik R; Thomas M; Senthil M
    Med J Aust; 1994 Feb; 160(4):197-201. PubMed ID: 8309391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.
    Deuffic-Burban S; Atsou K; Viget N; Melliez H; Bouvet E; Yazdanpanah Y
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):471-81. PubMed ID: 20202306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.